Company / Current Liabilities
Emergent BioSolutions Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$132.2M
FY2025
5-year range
$132.2M / $1.2B
FY2021-FY2025
Trend
-18.6%
vs FY2024
Sector context
#82 of 213
Health Care
What the data says
At $132M, Emergent BioSolutions Inc.'s current liabilities ranks #132 of 213 in the Health Care sector. Current Liabilities has declined for 3 consecutive years, from $1.2B in FY2022 to $132M in FY2025.
Based on SEC 10-K filings.
$132M in FY2025 with a 5-year CAGR of -19.2%.
Improved from $651M to $132M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -52.4%
- 5-Year CAGR
- -19.2%
- 10-Year CAGR
- -
Sector benchmark
#132 of 213 in Health CareTop 62% of 213This company $132.2M Sector average $1.6B
▼
-91.7% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s current liabilities has declined for 3 consecutive years.
- 5-year CAGR of -19.2%, indicating a declining trend.
- In FY2025, current liabilities decreased 18.6% year-over-year.
- Ranks #82 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $132.2M | -18.6% |
| FY2024 | $162.4M | -75.1% |
| FY2023 | $651.3M | -47.0% |
| FY2022 | $1.2B | +228.8% |
| FY2021 | $373.8M | -2.8% |
| FY2020 | $384.5M | +77.8% |
| FY2019 | $216.3M | +7.9% |
| FY2018 | $200.4M | +100.2% |
| FY2017 | $100.1M | -5.4% |
| FY2016 | $105.9M | +6.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026